ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201
January 09, 2020AD, a common condition that can have multiple negative effects on the lives of affected individuals, is a chronic inflammatory disorder characterized by eczematous skin lesions, itch, localized pain, and sleep disturbances. It is also a common condition,
Pharma Sources Insight January 2025
